Close Menu

NEW YORK (GenomeWeb) – Danaher today reported an 11 percent year-over-year increase in its fourth quarter revenues, with its Life Sciences and Diagnostics segments growing above the companywide rate.

Danaher also announced a transition plan for Daniel Comas, who will step down as CFO on Jan. 1, 2019, to be replaced by Matthew McGrew.

For the three months ended Dec. 31, 2017, total revenues came in at $5.09 billion, up from $4.58 billion in the year-ago period, and beating the consensus Wall Street estimate of $4.98 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.